Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1051-1060 of 1,467) with videos related to

Pageof 147
Sort By:
Journal of Animal Science|December 12, 2024
An industry survey of the composition and variability of soybean gums and soapstocks across US soybean processing plantsKatelyn N Gaffield, Robert D Goodband, Joel M DeRouchey, et al.
Nature Communications|April 30, 2026
Functional impact of genetic background on variable expressivity in neurodevelopmental disordersJiawan Sun, Serena Noss, Corrine Smolen, et al.
Arthritis and Rheumatism|March 30, 2007
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritisEsther Jimenez-Boj, Iris Nöbauer-Huhmann, Beatrice Hanslik-Schnabel, et al.
The Journal of Rheumatology|June 7, 2007
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritisSudha Visvanathan, Joseph C Marini, Josef S Smolen, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
BMJ Open|September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factorsEsben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Rheumatology (Oxford, England)|April 17, 2015
Quality indicators in rheumatoid arthritis: results from the METEOR databaseVictoria Navarro-Compán, Josef S Smolen, Tom W J Huizinga, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritisAdelheid Korb-Pap, Athanasios Stratis, Katja Mühlenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Rational design of a ligand-controlled protein conformational switchOnur Dagliyan, David Shirvanyants, Andrei V Karginov, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Pageof 147

Showing results (1051-1060 of 1,467) with videos related to

Sort By:
Pageof 147
Journal of Animal Science|December 12, 2024
An industry survey of the composition and variability of soybean gums and soapstocks across US soybean processing plantsKatelyn N Gaffield, Robert D Goodband, Joel M DeRouchey, et al.
Nature Communications|April 30, 2026
Functional impact of genetic background on variable expressivity in neurodevelopmental disordersJiawan Sun, Serena Noss, Corrine Smolen, et al.
Arthritis and Rheumatism|March 30, 2007
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritisEsther Jimenez-Boj, Iris Nöbauer-Huhmann, Beatrice Hanslik-Schnabel, et al.
The Journal of Rheumatology|June 7, 2007
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritisSudha Visvanathan, Joseph C Marini, Josef S Smolen, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
BMJ Open|September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factorsEsben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Rheumatology (Oxford, England)|April 17, 2015
Quality indicators in rheumatoid arthritis: results from the METEOR databaseVictoria Navarro-Compán, Josef S Smolen, Tom W J Huizinga, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritisAdelheid Korb-Pap, Athanasios Stratis, Katja Mühlenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Rational design of a ligand-controlled protein conformational switchOnur Dagliyan, David Shirvanyants, Andrei V Karginov, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Pageof 147